TLR3 and myeloid sarcoma: However, a recent study reported that TLR3 activated by polyinosinic-polycytidylic acid on proinflammatory cytokine-pretreated astrocytes significantly promoted the production of fibronectin aggregation and led to remyelination failure in MS (73).